These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 9486993

  • 1. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.
    Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW.
    N Engl J Med; 1998 Mar 05; 338(10):645-52. PubMed ID: 9486993
    [Abstract] [Full Text] [Related]

  • 2. The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes.
    Savage S, Johnson Nagel N, Estacio RO, Feig PU, MacCarthy EP, Lukken NJ, Ziegler R, Schrier RW.
    Online J Curr Clin Trials; 1993 Nov 24; Doc No 104():[6250 words; 128 paragraphs]. PubMed ID: 8305994
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.
    Estacio RO, Schrier RW.
    Am J Cardiol; 1998 Nov 12; 82(9B):9R-14R. PubMed ID: 9822137
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
    Havranek EP, Esler A, Estacio RO, Mehler PS, Schrier RW, Appropriate Blood Pressure Control in Diabetes Trial.
    Am Heart J; 2003 Jun 12; 145(6):993-8. PubMed ID: 12796754
    [Abstract] [Full Text] [Related]

  • 5. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO, Jeffers BW, Gifford N, Schrier RW.
    Diabetes Care; 2000 Apr 12; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [Abstract] [Full Text] [Related]

  • 6. Calcium-channel blockers for hypertension--uncertainty continues.
    Cutler JA.
    N Engl J Med; 1998 Mar 05; 338(10):679-81. PubMed ID: 9486999
    [No Abstract] [Full Text] [Related]

  • 7. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb 05; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 8. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Tuomilehto J, Rastenyte D, Birkenhäger WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R.
    N Engl J Med; 1999 Mar 04; 340(9):677-84. PubMed ID: 10053176
    [Abstract] [Full Text] [Related]

  • 9. Nisoldipine and myocardial infarction.
    Osende JI.
    N Engl J Med; 1998 Jul 09; 339(2):126; author reply 127. PubMed ID: 9669898
    [No Abstract] [Full Text] [Related]

  • 10. Nisoldipine and myocardial infarction.
    Walker AM.
    N Engl J Med; 1998 Jul 09; 339(2):126; author reply 127. PubMed ID: 9669899
    [No Abstract] [Full Text] [Related]

  • 11. Nisoldipine and myocardial infarction.
    Molitch ME.
    N Engl J Med; 1998 Jul 09; 339(2):126-7; author reply 127. PubMed ID: 9669900
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep 09; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 13. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 14. Appropriate Blood Pressure Control in NIDDM (ABCD) Trial.
    Schrier RW, Estacio RO, Jeffers B.
    Diabetologia; 1996 Dec 25; 39(12):1646-54. PubMed ID: 8960857
    [Abstract] [Full Text] [Related]

  • 15. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L.
    J Hypertens Suppl; 1999 Feb 25; 17(1):S9-13. PubMed ID: 10340838
    [Abstract] [Full Text] [Related]

  • 16. The calcium channel antagonist debate: recent developments.
    Lubsen J.
    Eur Heart J; 1998 Aug 25; 19 Suppl I():I3-7. PubMed ID: 9743437
    [Abstract] [Full Text] [Related]

  • 17. Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension.
    Schrier RW, Estacio RO.
    N Engl J Med; 2000 Dec 28; 343(26):1969. PubMed ID: 11186674
    [No Abstract] [Full Text] [Related]

  • 18. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J, ALLHAT Collaborative Research Group.
    Arch Intern Med; 2006 Nov 13; 166(20):2191-201. PubMed ID: 17101936
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 Nov 13; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 20. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M, Lang R, Rachmani R, Lishner M.
    Arch Intern Med; 1996 Feb 12; 156(3):286-9. PubMed ID: 8572838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.